• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Amyloidosis relapsing after autologous stem cell transplantation treated with bortezomib: normalization of detectable serum-free light chains and reversal of tissue damage with improved suitability for transplant.用硼替佐米治疗自体干细胞移植后复发的淀粉样变性：可检测的游离轻链正常化以及组织损伤逆转，移植适应性改善
Haematologica. 2010 Mar;95(3):519-21. doi: 10.3324/haematol.2009.013102. Epub 2009 Nov 10.
2
Induction bortezomib in Al amyloidosis followed by high dose melphalan and autologous stem cell transplantation: a single institution retrospective study.硼替佐米诱导治疗伴随后续大剂量美法仑和自体干细胞移植用于治疗AL淀粉样变性：一项单机构回顾性研究
Clin Lymphoma Myeloma Leuk. 2014 Oct;14(5):424-430.e1. doi: 10.1016/j.clml.2014.02.003. Epub 2014 Feb 16.
3
Isolated autonomic failure without evident somatic polyneuropathy in AL amyloidosis.AL淀粉样变性中无明显躯体多发性神经病的孤立性自主神经功能衰竭。
Amyloid. 2014 Sep;21(3):218-20. doi: 10.3109/13506129.2014.935321. Epub 2014 Jun 27.
4
Improvement of mucocutaneous involvement of immunoglobulin light chain amyloidosis after chemotherapy and hematopoietic stem cell transplantation for multiple myeloma.多发性骨髓瘤化疗及造血干细胞移植后免疫球蛋白轻链淀粉样变性的黏膜皮肤受累情况改善
J Dermatol. 2013 Sep;40(9):768-9. doi: 10.1111/1346-8138.12233. Epub 2013 Jul 16.
5
Sustained improvement in cardiac function with persistent amyloid deposition in a patient with multiple myeloma-associated cardiac amyloidosis treated with bortezomib.硼替佐米治疗多发性骨髓瘤相关心脏淀粉样变性患者，心肌功能持续改善，淀粉样沉积物持续存在。
Int J Hematol. 2010 Nov;92(4):655-8. doi: 10.1007/s12185-010-0710-x. Epub 2010 Oct 27.
6
Bortezomib in systemic AL amyloidosis: a single center experience.硼替佐米治疗系统性AL淀粉样变性：单中心经验
Amyloid. 2011 Jun;18 Suppl 1:148-50. doi: 10.3109/13506129.2011.574354055.
7
Bortezomib (Velcade) treatment of AL amyloidosis: Indiana University experience.硼替佐米（万珂）治疗 AL 型淀粉样变性：印第安纳大学的经验。
Amyloid. 2011 Jun;18 Suppl 1:151. doi: 10.3109/13506129.2011.574354056.
8
Quick response to bortezomib plus dexamethasone in a patient with AL amyloidosis in first relapse.硼替佐米联合地塞米松对首次复发的AL淀粉样变性患者的快速反应
Amyloid. 2011 Jun;18 Suppl 1:152-4. doi: 10.3109/13506129.2011.574354057.
9
Still no certainty about the role of upfront bortezomib among patients with AL amyloidosis.对于硼替佐米在初治的AL淀粉样变性患者中的作用仍不明确。
Leukemia. 2014 Dec;28(12):2273-5. doi: 10.1038/leu.2014.271.
10
Bortezomib treatment followed by a second non-myeloablative allogeneic stem cell transplant in two previously autografted patients with multiple myeloma relapse.硼替佐米治疗后，对两名先前接受自体移植且多发性骨髓瘤复发的患者进行第二次非清髓性异基因干细胞移植。
Haematologica. 2005 Jun;90(6):861-2.

引用本文的文献

1
Autologous stem cell transplant for Al amyloidosis.用于治疗淀粉样变性的自体干细胞移植。
Bone Marrow Res. 2012;2012:238961. doi: 10.1155/2012/238961. Epub 2012 May 16.

本文引用的文献

1
Bortezomib in the front-line treatment of multiple myeloma.硼替佐米用于多发性骨髓瘤的一线治疗。
Expert Rev Anticancer Ther. 2008 Jul;8(7):1053-72. doi: 10.1586/14737140.8.7.1053.
2
Efficacy of bortezomib in systemic AL amyloidosis with relapsed/refractory clonal disease.硼替佐米对复发/难治性克隆性疾病的系统性 AL 淀粉样变性的疗效。
Haematologica. 2008 Feb;93(2):295-8. doi: 10.3324/haematol.11627.
3
Perspectives in treatment of AL amyloidosis.AL淀粉样变性的治疗前景
Br J Haematol. 2008 Feb;140(4):365-77. doi: 10.1111/j.1365-2141.2007.06936.x. Epub 2007 Dec 19.
4
Long-term outcome of patients with AL amyloidosis treated with high-dose melphalan and stem-cell transplantation.接受大剂量美法仑和干细胞移植治疗的AL淀粉样变性患者的长期预后。
Blood. 2007 Nov 15;110(10):3561-3. doi: 10.1182/blood-2007-07-099481. Epub 2007 Aug 2.
5
Transplantation for amyloidosis.淀粉样变性的移植治疗。
Curr Opin Oncol. 2007 Mar;19(2):136-41. doi: 10.1097/CCO.0b013e32801494c6.
6
Current and emerging views and treatments of systemic immunoglobulin light-chain (Al) amyloidosis.系统性免疫球蛋白轻链（AL）淀粉样变性的当前及新出现的观点与治疗方法
Contrib Nephrol. 2007;153:195-210. doi: 10.1159/000096768.
7
Superior survival in primary systemic amyloidosis patients undergoing peripheral blood stem cell transplantation: a case-control study.接受外周血干细胞移植的原发性系统性淀粉样变性患者的较高生存率：一项病例对照研究。
Blood. 2004 May 15;103(10):3960-3. doi: 10.1182/blood-2003-12-4192. Epub 2004 Jan 22.
8
Molecular mechanisms of amyloidosis.淀粉样变性的分子机制
N Engl J Med. 2003 Aug 7;349(6):583-96. doi: 10.1056/NEJMra023144.
9
Outcome in systemic AL amyloidosis in relation to changes in concentration of circulating free immunoglobulin light chains following chemotherapy.化疗后系统性 AL 淀粉样变性的预后与循环游离免疫球蛋白轻链浓度变化的关系
Br J Haematol. 2003 Jul;122(1):78-84. doi: 10.1046/j.1365-2141.2003.04433.x.
10
Myeloablative chemotherapy with stem cell rescue for the treatment of primary systemic amyloidosis: a status report.采用干细胞救援的清髓性化疗治疗原发性系统性淀粉样变性：现状报告。
Bone Marrow Transplant. 2000 Mar;25(5):465-70. doi: 10.1038/sj.bmt.1702178.

Amyloidosis relapsing after autologous stem cell transplantation treated with bortezomib: normalization of detectable serum-free light chains and reversal of tissue damage with improved suitability for transplant.

作者信息

Brunvand Mark W, Bitter Mitchell

出版信息

Haematologica. 2010 Mar;95(3):519-21. doi: 10.3324/haematol.2009.013102. Epub 2009 Nov 10.

DOI:10.3324/haematol.2009.013102
PMID:19903681
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2833087/
Abstract
摘要